CYP2D6 Genotype on the Clinical Effect of Tamoxifen
- Conditions
- Breast NeoplasmsTamoxifenGenotypeCYP2D6
- Interventions
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2009-09-09
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 922
- Registration Number
- NCT00973037
- Locations
- π°π·
Korea University Anam Hopital, Seoul, Korea, Republic of
CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)
- Conditions
- ArthritisBreast NeoplasmsArthralgiaGenetic Polymorphism
- Interventions
- Drug: Aromatase Inhibitor(Femara or Arimidex)
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2009-09-09
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT00973505
- Locations
- π°π·
Korea University Anam Hopital, Seoul, Korea, Republic of
Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes
Phase 4
Completed
- Conditions
- DiabetesHypertensionCoronary Artery Disease
- Interventions
- First Posted Date
- 2008-01-24
- Last Posted Date
- 2015-09-03
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT00599885
- Locations
- π°π·
Korea University Anam Hospital, Seoul, Korea, Republic of
Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness
Phase 4
- Conditions
- Diabetes Mellitus, Type 2Metabolic Syndrome X
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-12-14
- Last Posted Date
- 2007-12-14
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT00573950
- Locations
- π°π·
Korea Univerisity Anam Hospital, Seoul, Korea, Republic of
Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial Infarction
Phase 4
Completed
- Conditions
- Acute Myocardial Infarction
- First Posted Date
- 2007-09-28
- Last Posted Date
- 2012-04-09
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT00536887
- Locations
- π°π·
Korea University Anam Hospital, Seoul, Korea, Republic of
The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers
Phase 4
Completed
- Conditions
- Diabetes MellitusCoronary Artery Stenosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-06-29
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT00494559
- Locations
- π°π·
Korea University Anam Hospital, Seoul, Korea, Republic of
A Phase β ‘ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer
Phase 2
Completed
- Conditions
- Neoplasm MetastasisPancreatic Neoplasm
- Interventions
- Drug: gemcitabine, TS-1
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2007-11-01
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 38
- Registration Number
- NCT00436423
- Locations
- π°π·
YeulHong Kim, Seoul, Korea, Republic of
The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome
Phase 4
Completed
- Conditions
- Metabolic Syndrome
- First Posted Date
- 2006-04-14
- Last Posted Date
- 2011-07-01
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00314561
- Locations
- π°π·
Korea University Anam Hospital, Seoul, Korea, Republic of